340B Orphan Drug Rule Review Passes 90-Day Mark

340B Orphan Drug Rule Review Passes 90-Day Mark

May 3rd, 2013
HRSA says it is still working with OMB to finalize regulationMay 2, 2013 – The Health Resources and Services Administration (HRSA) “is continuing ...

Sentry Puts the Customer First – from Contract signing to 340B Program Audit Support

Sentry Puts the Customer First – from Contract signing to 340B Program Audit Support

April 22nd, 2013
Sentry Data Systems, Inc. is a healthcare technology company offering a Business Intelligence (BI) platform that provides pharmacy procurement management, revenue cycle management ...

URGENT 340B Update: GPO Prohibition Deadline Extended

URGENT 340B Update: GPO Prohibition Deadline Extended

April 5th, 2013
HRSA has announced that the GPO Prohibition Update – Policy Release 2013-1 deadline has been extended until August 7, 2013 for those Covered ...

Sentry’s Business Intelligence Platform is Prepared for 340B GPO Policy Update Requirements

Sentry’s Business Intelligence Platform is Prepared for 340B GPO Policy Update Requirements

March 11th, 2013
Sentry Releases FAQs on GPO Prohibition Policy Sentry Data Systems, Inc. is reaching out to the 340B community to address concerns regarding Covered ...

HIMSS Lunch & Learn – Pharmacy Data Analytics: Empowering Your Hospital with Actionable Data to Impact Your Sustainability

HIMSS Lunch & Learn – Pharmacy Data Analytics: Empowering Your Hospital with Actionable Data to Impact Your Sustainability

March 10th, 2013
Dawn DeAngelo, Sentry’s Chief Pharmacy Officer, gave a presentation at the HIMMS 13 Annual Conference about how hospitals can use pharmacy data to ...

About

SentryDS.com is your source for all news and events related to healthcare information technology, Sentry Data Systems and its products.

Contributors

Travis Leonardi, RPh., C.P.
President, CEO
William D. Kirsh DO, MPH
Chief Medical Officer
Lidia Rodriguez-Hupp
Senior Vice President
Dawn C. DeAngelo
Chief Pharmacy Officer

Archive